Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Contraceptive Pills Halve Size of Women’s Ovaries

By HospiMedica International staff writers
Posted on 20 Aug 2014
A new study has found that birth control pills can reduce women’s ovaries upward of 50% in size, but the that the ovaries appear to return to normal after cessation.

Researchers at Rigshospitalet (Copenhagen, Denmark) and Copenhagen University (Denmark) conducted a study involving 833 women, aged 19–46, of whom almost 30% took contraceptive pills. More...
The women underwent two tests to indicate how their ovaries were aging; anti-Muthe higher (AMH) blood levels, and the AFC test, which uses ultrasound scanning of antral follicles—containing immature eggs that released each month during menstruation—to indicate how many eggs from the ovaries are recruited for ovulation, a measure of fertility.

The results of the study showed that for young women (19–29.9 years of age), the ovaries were reduced by 52%, compared with women who were not on the pill. The result of the AMH test was 19% lower for women who took birth control pills, while the result of the AFC test was reduced by 16%, compared with women who did not take birth control pills. The study was presented at the European Society of Human Reproduction and Embryology (ESHRE) fertility conference, held during July 2014, in Munich (Germany).

“Young women typically have well-developed and well-functioning ovaries, while women approaching their menopause have smaller ovaries with reduced egg production," said lead author and study presenter Kathrine Birch Petersen, MD. “We noticed that a number of young women who took birth control pills had ovaries that looked like they were approaching the menopause. That the size of the ovaries is reduced so much is quite convincing.”

The researchers stressed that the results of the study do not apply to women who use contraceptive mini-pills, hormone spirals, and contraceptive implants.

Related Links:

Rigshospitalet
Copenhagen University



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The new 3D heart mapping system visualizes all four chambers in real time (Photo courtesy of UPV)

Whole-Heart Mapping Technology Provides Comprehensive Real-Time View of Arrhythmias

Cardiac arrhythmias can be difficult to diagnose and treat because current mapping systems analyze the heart one chamber at a time. This fragmented view forces clinicians to infer electrical activity they... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.